Can-fite Biopharma (CANF) analyst forecast and price target
Analyst forecast
Consensus of 1 analyst rating
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $8.00 from $5.00 | Jul 2, 2026 |
| D. Boral Capital | Upgraded | Hold → Buy | $7.00 | May 13, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 from $2.50 | May 12, 2026 |
| D. Boral Capital | Maintained | Buy | $4.00 from $11.00 | Dec 17, 2025 |
| D. Boral Capital | Maintained | Buy | $11.00 | Nov 18, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $2.50 | Nov 4, 2025 |
| D. Boral Capital | Maintained | Buy | $11.00 | Sep 16, 2025 |
| D. Boral Capital | Maintained | Buy | $11.00 | Sep 2, 2025 |
| D. Boral Capital | Maintained | Buy | $10.00 | Jul 29, 2025 |
| D. Boral Capital | Maintained | Buy | $10.00 | Apr 15, 2025 |
| D. Boral Capital | Maintained | Buy | $10.00 | Mar 21, 2025 |
| D. Boral Capital | Maintained | Buy | $10.00 | Mar 20, 2025 |
| D. Boral Capital | Maintained | Buy | $10.00 | Mar 18, 2025 |
| D. Boral Capital | Maintained | Buy | $10.00 | Mar 3, 2025 |
| D. Boral Capital | Maintained | Buy | $10.00 | Feb 18, 2025 |
| D. Boral Capital | Maintained | Buy | $10.00 | Dec 31, 2024 |
| D. Boral Capital | Maintained | Buy | $10.00 | Dec 5, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $18.00 | Nov 12, 2024 |
| EF Hutton | Maintained | Buy | $10.00 | Oct 10, 2024 |
| EF Hutton | Maintained | Buy | $10.00 | Sep 24, 2024 |
Frequently asked questions
Is CANF a buy, sell, or hold?
Analysts covering Can-fite Biopharma currently average a Buy rating: 1 buy, 0 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on CANF?
On Jul 2, 2026, HC Wainwright & Co. maintained Can-fite Biopharma at Buy with a price target of $8.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
